Application of Calculated Panel Reactive Antibody Using HLA Frequencies in Koreans
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Background: Introduction of the Luminex panel reactive antibody (PRA)-single antigen (SA) assay has increased the detection rates of unacceptable antigens in sensitized patients; the calculated PRA (CPRA) level represents the percentage of actual organ donors that express 1 or more of these unacceptable antigens. We developed a CPRA calculator based on the HLA frequencies in Koreans to measure sensitization levels in Korean patients. Methods: To develop the calculator, we obtained the HLA-A, HLA-B, and HLA-DR phenotypes of 1,622 Koreans, and compared these with previously reported frequencies in Koreans. Sera from patients awaiting kidney transplantation were tested for HLA antibodies by Luminex PRA-screen, PRA-identification (ID), and PRA-SA assays. The measured %PRA from the PRA-screen (N=55) and PRA-ID (N=71) were compared to the %CPRA for the unacceptable antigens obtained from PRA-SA. Results: Phenotype frequencies used for the CPRA calculator agreed with previously reported data. The concordance rates among the 3 PRA methods for the detection of class I and class II antibodies were 76.1-81.8% (kappa, 0.519-0.636) and 72.7-83.6% (0.463-0.650), respectively. For the detection of broadly sensitized sera (>50% or >80%), the concordance rates were over 80%. In sera with 80-100% CPRA, 91.7% and 94.4% of the samples had concordant results (80-100% PRA) in the PRA-screen and PRA-ID assay, respectively. Conclusions: Although further clinical studies are required to confirm the benefits of CPRA values, adoption of CPRA analysis based on HLA frequencies in Koreans may be useful for sensitization measurements and organ-allocation algorithms.
Abstract
Background: Introduction of the Luminex panel reactive antibody (PRA)-single antigen (SA) assay has increased the detection rates of unacceptable antigens in sensitized patients; the calculated PRA (CPRA) level represents the percentage of actual organ donors that express 1 or more of these unacceptable antigens. We developed a CPRA calculator based on the HLA frequencies in Koreans to measure sensitization levels in Korean patients. Methods: To develop the calculator, we obtained the HLA-A, HLA-B, and HLA-DR phenotypes of 1,622 Koreans, and compared these with previously reported frequencies in Koreans. Sera from patients awaiting kidney transplantation were tested for HLA antibodies by Luminex PRA-screen, PRA-identification (ID), and PRA-SA assays. The measured %PRA from the PRA-screen (N=55) and PRA-ID (N=71) were compared to the %CPRA for the unacceptable antigens obtained from PRA-SA. Results: Phenotype frequencies used for the CPRA calculator agreed with previously reported data. The concordance rates among the 3 PRA methods for the detection of class I and class II antibodies were 76.1-81.8% (kappa, 0.519-0.636) and 72.7-83.6% (0.463-0.650), respectively. For the detection of broadly sensitized sera (>50% or >80%), the concordance rates were over 80%. In sera with 80-100% CPRA, 91.7% and 94.4% of the samples had concordant results (80-100% PRA) in the PRA-screen and PRA-ID assay, respectively. Conclusions: Although further clinical studies are required to confirm the benefits of CPRA values, adoption of CPRA analysis based on HLA frequencies in Koreans may be useful for sensitization measurements and organ-allocation algorithms.
참고문헌 (23)
- Cecka JM, "Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches", Am J Transplant, 11, pp.719~724 (2011)
- Cecka JM, "Calculated PRA (CPRA): the new measure of sensitization for transplant candidates", Am J Transplant, 10, pp.26~29 (2010)
- 정선경, "HLA 동종항체 선별을 위한 ELISA 및 Luminex Panel Reactive Antibody 검사의 비교평가", Annals of Laboratory Medicine, 29(5), pp.473~480 (2009), 대한진단검사의학회
- Bray RA, "Strategies for human leukocyte antigen antibody detection", Curr Opin Organ Transplant, 14, pp.392~397 (2009)
- Howell WM, "The HLA system: immunobiology, HLA typing, antibody screening and crossmatching techniques", J Clin Pathol, 63, pp.387~390 (2010)
- 노은연, "DNA 형별검사에 의한 한국인의 HLA-A, -B, -DR 형별 및 일배체형의 분포", Annals of Laboratory Medicine, 23(6), pp.420~430 (2003), 대한진단검사의학회
- 황동희, "한국인에서 Human Leukocyte Antigen-A, -B, -DR 대립유전자와 일배체형 빈도: 제대혈 1,500단위의 DNA 형별검사", Annals of Laboratory Medicine, 28(6), pp.465~474 (2008), 대한진단검사의학회
- Raymond M, "GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism", J Hered, 86, pp.248~249 (1995)
- Rousset F, "Genepop’007: a complete re-implementation of the genepop software for Windows and Linux", Mol Ecol Resour, 8, pp.103~106 (2008)
- Zachary AA, "Defining unacceptable HLA antigens", Curr Opin Organ Transplant, 13, pp.405~410 (2008)
- Lee KW, "Serologic ambiguity and allelic frequency of the HLA-B40 family in the Korean population", Tissue Antigens, 49, pp.383~388 (1997)
- 이경화, "Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -DQB1 genes in the Korean population", TISSUE ANTIGENS, 65, pp.437~447, BLACKWELL PUBLISHING
- Kerman R, "The crossmatch may still be the most clinically relevant histocompatibility test performed", pp.227~229 (2007), Clin Transpl
- Kerman RH, "Understanding the sensitized patient", Heart Fail Clin, 3, pp.1~9 (2007)
- Phelan D, "Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay", Hum Immunol, 70, pp.584~588 (2009)
- Aubert V, "Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant", Hum Immunol, 70, pp.580~583 (2009)
- Ho EK, "Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation", Transpl Immunol, 20, pp.61~67 (2008)
- Bray RA, "Calculated PRA: a process whose time has come or ‘Déjà vu’ all over again?", Am J Transplant, 11, pp.650~651 (2011)
- Vaidya S, "DP reactive antibody in a zero mismatch renal transplant pair", Hum Immunol, 68, pp.947~949 (2007)
- Goral S, "Preformed donor-directed anti-HLA-DP antibodies may be an impediment to successful kidney transplantation", Nephrol Dial Transplant, 23, pp.390~392 (2008)
- Bray RA, "Transplanting the highly sensitized patient: The emory algorithm", Am J Transplant, 6, pp.2307~2315 (2006)
- Appel JZ, "Role of flow cytometry to define unacceptable HLA antigens in lung transplant recipients with HLA-specific antibodies", Transplantation, 81, pp.1049~1057 (2006)
- Leffell MS, "Improved definition of human leukocyte antigen frequencies among minorities and applicability to estimates of transplant compatibility", Transplantation, 83, pp.964~972 (2007)